secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001493152-24-030540
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma enters $150K AUD loan agreement with 12% interest, due Nov 2024
--------------------------------------------------------------------------------

- Loan of $150,000 AUD effective Aug 1, 2024, with maturity Nov 1, 2024.
- Interest rate 12% per annum; prepayable at any time without penalty.
- Proceeds will be used for general working capital purposes.
- Loan issued under private placement exemption per Section 4(a)(2) and Rule 506.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224030540/0001493152-24-030540-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224030540/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-030540

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer